ESM1 and atherosclerosis: Since obesity is considered a state associated with low-grade, persistent, chronic inflammation that leads to atherogenesis onset and atherosclerotic cardiovascular disease (ASCVD) [6,12], it is expected that the serum endocan level (as a proinflammatory mediator) will be increased in obese individuals.